Page last updated: 2024-09-04

gadolinium dtpa and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

gadolinium dtpa has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies

Compound Research Comparison

Studies (gadolinium dtpa)	Trials (gadolinium dtpa)	Recent Studies (post-2010) (gadolinium dtpa)	Studies (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)	Trials (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)	Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
12,654	664	4,051	3,859	8	1,052

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Astradsson, A; Brownell, AL; Choi, JK; Hallett, PJ; Isacson, O; Jenkins, BG; Levesque, MA; McDowell, JS; Spealman, RD	1

Other Studies

1 other study(ies) available for gadolinium dtpa and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies. Neurobiology of disease, 2009, Volume: 35, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Blood-Brain Barrier; Brain; Dyskinesia, Drug-Induced; Gadolinium DTPA; Levodopa; Macaca fascicularis; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Time Factors	2009

Article

Year

The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies.

Neurobiology of disease, 2009, Volume: 35, Issue:3

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Blood-Brain Barrier; Brain; Dyskinesia, Drug-Induced; Gadolinium DTPA; Levodopa; Macaca fascicularis; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Time Factors

2009